SPOTLIGHT -
4D Molecular Therapeutics announces FDA clearance of IND application for 4D-150 genetic medicine for the treatment of DME
Commercial real estate and your practice, part two with Colin Carr
Novel gene therapy shows promise for treating multiple eye diseases
Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)
Harrow announces permanent, product-specific J-Code for chloroprocaine hydrochloride ophthalmic gel for ocular surface anesthesia
Orbis announces 3-year partnership with HOYA Vision Care
